Linking CSC plasticity to therapeutic resistance - mechanisms and novel therapeutic strategies in hepatocellular carcinoma – Stephanie Ma from The University of Hong Kong, Hong Kong SAR, China, presented her research employing in vivo lineage tracing combined with single-cell RNA sequencing (scRNA-seq) to explore the heterogeneity and dynamic behavior of Prom1-positive (CD133-positive) HCC cells. Here, PROM1 is linked to hepatocellular carcinoma.